ACE and hepatocellular carcinoma: The results support DCP as an optimal diagnostic marker of HCC, but attention needs to be paid to the liver function of patients for false positivity; serum DCP may act as a therapeutic marker for surgical and interventional therapies of HCC, but remains elusive in systemic treatment.